Biologics News

Patients with rheumatoid arthritis who are Black are less likely to receive a biologic, and more likely to use glucocorticoids, than those who are white, according to a speaker at ACR Convergence 2020.

Patients with primary knee osteoarthritis who received at least 3 months of oral methotrexate demonstrated significant improvement in physical function and inflammation vs. patients who received glucosamine, noted a presenter at ACR 2020.

Glucocorticoids should no longer be the “default” option for many patients with rheumatoid arthritis, according to authors of a new recommendation document presented at ACR Convergence 2020.

Despite minimal evidence available, authors of the 2020 ACR juvenile idiopathic arthritis guidelines emerged with nearly 50 recommendations, emphasizing early use of biologics, regular immunizations and reduced reliance on corticosteroids.

Orthofix Medical Inc. announced the launch of the O-Genesis graft delivery system and the AlloQuent structural allograft Q-Pack, according to a press release.

CartiHeal’s Agili-C implant for cartilage lesions in arthritic and nonarthritic joints has received FDA breakthrough device designation, according to a press release.

During a meeting of the Orthopaedic and Rehabilitation Devices Panel of the FDA Medical Devices Advisory Committee, panel members found noninvasive bone growth stimulators worthy of down-classification.

Patients treated for osteoarthritis-related knee pain with cooled radiofrequency ablation saw greater improvements in pain relief and knee function compared with patients treated with a single injection of hyaluronic acid, according to a recent study.

Gilead announced the FDA has issued a complete response letter regarding the new drug application for filgotinib as a treatment for moderately to severely active rheumatoid arthritis.

Osteochondral autograft transplantation has shown positive clinical outcomes in the treatment of medium-sized osteochondral lesions of the talus, according to a study by researchers at Hospital for Special Surgery.